{"id":"NCT00687102","sponsor":"Wake Forest University","briefTitle":"Cognition in the Study of Tamoxifen and Raloxifene","officialTitle":"Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-10","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2008-05-30","resultsPosted":"2018-01-23","lastUpdate":"2018-09-12"},"enrollment":1498,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Cognition","Aging"],"interventions":[{"type":"DRUG","name":"tamoxifen","otherNames":["Nolvadex"]},{"type":"DRUG","name":"raloxifene","otherNames":["Evista, Keoxifene"]}],"arms":[{"label":"Star participants assigned to Tamoxifen","type":"EXPERIMENTAL"},{"label":"Star participants assigned to Raloxifene","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.","primaryOutcome":{"measure":"Mean Change From Baseline on the the Benton Visual Retention Test Scores by Treatment Group","timeFrame":"Baseline and 3 Years","effectByArm":[{"arm":"Star Participants Assigned to Tamoxifen","deltaMin":-0.73,"sd":0.34},{"arm":"Star Participants Assigned to Raloxifene","deltaMin":-1.41,"sd":0.32}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":3},"locations":{"siteCount":134,"countries":["United States","Canada"]},"refs":{"pmids":["11156805","9409335","9799627"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":733},"commonTop":[]}}